- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, November 13, 2020
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article from The Daily Philadelphian cited an article published in a June 2017 supplement of The American Journal of Managed Care® (AJMC®). The supplement article, “Overview of Atopic Dermatitis,” indicated that the incidence of atopic dermatitis has increased 2- to 3-fold in industrialized nations, affecting approximately 15% to 20% of children and 1% to 3% of adults worldwide.
A piece by The Asbury Collegian referenced a contributor article published on AJMC.com, the website of AJMC®. The article, “The Deadly Costs of Insulin,” highlighted a 1200% increase on the original price of insulin, with a 1-month supply of insulin now costing about $275 compared with $21 in 1996.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
